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Small ubiquitin-like modifier-1 (SUMO-1) conjugating enzyme 9 (Ubc9) conjugates SUMO-1 to target proteins and
modulates cellular processes such as signal transduction, transcription regulation, and cell growth regulation. We demon-
strated here that the nucleocapsid protein (NP) of Hantaan virus (HTNV) was associated with Ubc9 and SUMO-1 in vivo.
Analysis of the interaction between the truncated NPs and Ubc9 revealed that the amino acid residues at the positions
between 101 and 238 in the NP were responsible for the interaction. Furthermore, a consensus binding motif of Ubc9 and
SUMO-1, MKAE, within this region, especially the second amino acid of the motif, K residue, was crucial for the interaction,
and the interaction was essential for the NP to be localized in the perinuclear region. These results indicate that the assembly
of the HTNV-NP is regulated by the interaction between the NP and Ubc9. This is the first report to demonstrate theKey Words: HTNV; NP; Ubc9; SUMO-1; localization of th
INTRODUCTION
Hantaviruses are associated with two severe diseases
in humans; hemorrhagic fever with renal syndrome
(HFRS) and hantavirus pulmonary syndrome (HPS) (7, 8,
21). Hantaan virus (HTNV) belongs to the genus Hanta-
virus, the family Bunyaviridae (29), and is an enveloped
virus with a diameter of 120 nm possessing tripartite-
segmented, single-stranded, negative sense RNA ge-
nomes (40). The small (S)-RNA encodes a viral nucleo-
capsid protein (NP) (41), The middle (M)-RNA encodes
two glycoproteins (G1 and G2) (42), and the large (L)-RNA
encodes an RNA-dependent RNA polymerase (39).
The NP of hantavirus, a protein with a molecular
weight of approximately 50 kDa, makes a viral ribo-
nucleocapsid (RNP) complex and directs viral RNA syn-
thesis. The NP localizes at the perinuclear region in
infected or NP-expressing cells (31). The NP of hantavi-
rus has been shown to form a multimer both in vivo and
in vitro (2) and its carboxyl (C)-terminal half and amino
(N)-terminal 40-amino acid (aa) residues are responsible
for the oligomerization of the NP (Fig. 1) (2). The N-
terminal 40-aa residues, in particular, may form trimeric
coiled-coils and contribute to NP trimerization. The NP-
trimers are thought to be intermediates in the assembly
of the RNP of hantavirus. After the formation of the
1 To whom correspondence and reprint requests should be ad-© 2003 Elsevier Science (USA)
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288NP-trimers and viral genomic RNA complexes, the NP-
trimers gradually assemble into long multimers together
with the RNAs. In addition, the viral RNAs bind directly to
the NP in vivo and in vitro (12, 17, 30, 35, 44, 45). Even
though a great deal of experimental data containing viral
replication and assembly has been recently reported, it
is still unclear how the virus assembles itself from the
various constituent viral structural proteins and viral
genomic RNAs, and what kinds of host proteins are
involved in the viral assembly or replication.
To address the host factors involved in the assembly of
the RNP and replication of HTNV, it is crucial to define
the cellular proteins interacting with the NP. In this study,
we focused on small ubiquitin-like modifier-1 (SUMO-1)
conjugating enzyme 9 (Ubc9) (27), which strongly inter-
acts with the NP in a yeast two-hybrid system. We
showed that Ubc9 interacted with the HTNV-NP and
identified the region within the HTNV-NP responsible for
binding to Ubc9. Furthermore, our present data indicated
that the interaction of the NP with Ubc9 determined the
localization of the NP at the perinuclear region where
viral replication and assembly should occur.
RESULTS
Interaction between the NP and the Ubc9
in yeast cells
In many viruses, the NPs play crucial roles in viral RNPinteraction of Ubc9 with a structural protein of negative-st
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assembly and replication (19, 20, 22). It might also be
possible that some cellular proteins are involved in theserand RN
e NP
events. Such cellular proteins should function through
the interaction with the NP. We have employed a yeast
two-hybrid system to define the cellular proteins that
interact with the NP of HTNV, using the cDNA library
derived from HeLa cells as a target. From 1  106
independent cDNA clones, we obtained 11 cDNA clones
that strongly interacted with the HTNV-NP in yeast cells.
The nucleotide sequences of 2 of these 11 clones were
identical to that of Ubc9 (49) (data not shown). We mea-
sured -Gal activity in the yeast cells cotransformed with
the bait-NP protein expression vector, pAS2–1-HTN-NP,
and the prey-Ubc9 protein expression vector, pACT2-
Ubc9. -Galactosidase (-Gal) activity in the yeast cells
transformed with both vectors was around 3400 times
higher than those in the yeast cells transformed with
pAS2–1-HTN-NP and pACT2 or pAS2–1 and pACT2-
Ubc9, and around 30 times higher than that in pAS2–1
and pACT2. This result indicates that the HTNV-NP in-
teracted with Ubc9 in the yeast cells.
Interaction between the NP and Ubc9
in mammalian cells
We also examined the interaction between the NP of
HTNV and the Ubc9 in mammalian cells. We transfected
293T cells with vectors for a mammalian two-hybrid sys-
tem, pBIND-HTNV-NP and pACT-Ubc9, and with pG5luc.
The luciferase activity in 293T cells transfected with
pBIND-HTN-NP and pACT-Ubc9 was higher than that in
the 293T cells transfected with pBIND-HTN-NP and
pACT, pBIND and pACT-Ubc9, or pBIND and pACT (Fig.
2A). Similar results were obtained in the experiment
using Vero E6 cells (data not shown). The results strongly
suggest that the HTNV-NP actually interacted with Ubc9
in mammalian cells.
To examine the subcellular localization of the NP and
Ubc9 in mammalian cells, enhanced green fluorescent
protein (EGFP)-tagged Ubc9 was transiently expressed
in HTNV-infected Vero E6 cells by transfection with
pEGFP-C1-Ubc9. As shown in Fig. 2B, EGFP-tagged
Ubc9 was mainly localized in the perinuclear region and
was colocalized with the NP of HTNV. The EGFP-tagged
Ubc9 and the NP were also colocalized in the cytoplasm
when these two proteins were both transiently ex-
pressed using the expression vectors (data not shown).
Mapping of the Ubc9-binding region within the
NP of HTNV
To determine the Ubc9-binding region within the NP,
we first introduced a series of deletions into the NP gene
of the yeast vector, pAS2-1-HTN-NP (Fig. 3), and co-
transformed Y190 yeast cells with the pAS2-1-HTN-NP
containing the deletions in the HTN-NP and pACT2-
FIG. 1. A schematic representation of the functional domains in the NP of hantaviruses. According to published reports, the functional domains
(shown as black bars) in the NP are as followes: 1) the NP trimerization signal (Alfadhli, et al., 2001) (2), 2) the perinuclear targeting signal (Ravkov,
et al., 2001) (31), 3) the nonspecific RNA binding region (Gott, et al., 1993) (12), 4) the specific RNA binding region (Xu, et al., 2002) (50), 6) the actin
microfilament binding region (Ravkov, et al., 1998) (32), 6) the Daxx binding site (Li et al., 2002) (23), and 7) the Ubc9/SUMO-1 binding region (in this
study).
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Ubc9. The -Gal activity of each transformant was mea-
sured to estimate the binding between the NP and Ubc9
(Fig. 3). The yeast cells cotransformed with pACT2-Ubc9
and pAS2-1-HTN-NP1–33, -1–100, -401–429, -334–
429, or -239–429 expressed -Gal at levels comparable
to that expressed in the cells cotransformed with the
pAS2-1-HTN-NP (wild-type (wt)-NP) and pACT2-Ubc9
(Fig. 3). On the other hand, the yeast cells co-trans-
formed with pACT2-Ubc9 and pAS2-1-HTNV-NP1–
133, -1–166, -1–199, or -169–429 expressed signifi-
cantly lower levels of -Gal (Fig. 3). Therefore, the aa resi-
dues at the aa positions between 101 and 238 of the NP are
thought to be necessary for the interaction with Ubc9.
Interaction between the NP of HTNV and SUMO-1 in
yeast cells
Ubc9 is an enzyme that covalently conjugates SUMO-1
at the K residue of the target proteins within the consen-
sus binding motif “()-lysine (K)-X-glutamic acid (E)” (38).
Therefore, we examined the binding of SUMO-1 with the
NP. Recently, Sampson et al., (38) reported that the bind-
ing consensus sequence motif for Ubc9 and SUMO-1
was “()KXE,” where  was any highly hydrophobic aa,
and X was any aa, respectively. We searched this con-
sensus sequence motif within the NP and found such a
motif “methionine (m)-K-alanine (A)-E” at the aa positions
between 188 and 191. Other strains of hantaviruses (4, 9,
46, 48) also have one or two binding motifs for Ubc9 and
SUMO-1 within the NP (Fig. 3B). This may indicate that
the binding of the NP with the Ubc9 and SUMO-1 is a
common feature for hantaviruses. We expected the
SUMO-1 modification (sumoylation) of the NP of HTNV,
because the NP interacts with Ubc9 at the aa positions
between 101 and 238, which contains the consensus
binding sequence. We constructed the prey vector,
pACT2-SUMO-1, as a counterpart of pAS2-1-HTN-NP in
the yeast two-hybrids interaction assay to examine the
binding between SUMO-1 and the NP. Y190 yeast cells
were cotransformed with both vectors and -Gal activity
in the cotransformed cells was measured. As expected,
the NP interacted with SUMO-1 in the yeast cells (Fig. 4).
However, -Gal activity in the yeast cells cotransformed
with both vectors was lower than that in the cells co-
transformed with pAS2-1-HTN-NP and pACT2-Ubc9.
FIG. 2. Interaction between the NP of HTNV and Ubc9 in the mammalian cells. (A) Mammalian two-hybrid assay for examining the interaction
between the NP and Ubc9 in 293T cells. Mammalian two-hybrid vectors, pBIND vector and pACT vector, were cotransfected with pG5 luc into 293T
cells (a). pBIND and pACT-Ubc9 (b), pBIND-HTN-NP and pACT (c), and pBIND-HTN-NP and pACT Ubc9 (d) were also cotransfected with pG5 luc.
Luciferase activities were measured at 48 h.p.t. as described in the text. The bait domain (BD), the NP, the prey domain (AD) and Ubc9 are illustrated.
The relative luciferase activities, the ratio of Firefry luciferase to Renilla luciferase, are shown as luciferase activities in the 293T cells transfected with
each set of illustrated vectors (a, b, c, and d) divided by that in the 293T cells transfected with pBIND, pACT and pG5 luc (a). (B) Colocalization of the
NP of HTNV and Ubc9 in 293T cells. The pEGFP-Ubc9 was transfected into HTNV-infected Vero E6 cells. At 48 h.p.t., cells were fixed and stained with
anti-HTN-NP MAb (51). The arrow shows the colocalization signal of EGFP-Ubc9 and HTNV-NP.
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Identification of the interaction site of the NP with
Ubc9 or SUMO-1
To define the interaction site of the NP with Ubc9 or
SUMO-1, we introduced substitutions at aa 189 (referred
to as NP-K189arginine (R) and NP-K189A), at aa 191
(NP-E191A and NP-E191aspartic acid (D)), and at both aa
189 and 191 (NP-K189A/E191A). We also deleted the
entire consensus motif (referred to as NP188–191) (Ta-
ble 1). As expected, -Gal activity in the yeast cells
cotransformed with pAS2-1-HTN-NP188–191 and
pACT2-Ubc9 was much lower than that in the yeast cells
cotransformed with pAS2-1-HTN-NP and pACT2-Ubc9
(Table 2). This result indicates that Ubc9 binds to the NP
at the consensus binding motif “MKAE” at aa 188–191.
The substitution of K to R in the motif of the NP (NP-
K189R) did not abolish the interaction with Ubc9 in vivo.
NP-K189R also interacted with SUMO-1 in the yeast sys-
tem (Table 1), even though the interaction between these
two proteins was weaker than that between the wt-NP
and SUMO-1. There was a weak interaction between
NP-K189A and Ubc9 (Table 1). The substitution of E to D
at aa 191 in the NP had no effect on the interaction with
FIG. 3. Mapping of the Ubc9 binding sites in the NP of HTNV. (A) A series of deletion mutants of the NP was expressed in yeast cells to determine
the Ubc9 binding sites in the NP. The wt-NP consisting of 429-aa is shown at the top. The NPs containing N-terminal deletions; NP1–33, NP1–100,
NP1–133, NP1–166 and NP1–199, and the NPs containing C-terminal deletions; NP401–429, NP334–429, NP239–429, NP169–429 are
shown in the figure. a) Color reactions were performed by yeast filter assays. When Ubc9 interacts with the mutant NPs, the color of the yeast colonies
changes from white to blue as described in the text. b) -Gal activities were measured by -Gal assay. The relative -Gal activities are shown as
the -Gal activity in the yeast expressing the mutant NPs and Ubc9 divided by that in the yeast expressing wt-NP and Ubc9. aa 101–238 of the NP
(shown by a thick black bar at bottom) was important for the binding with Ubc9. This region contains the MKAE sequence (aa 188–191) that is one
of the common consensus binding motifs (()KXE) for SUMO-1 and its conjugating enzyme, Ubc9 (see text). (B) The consensus binding motif in the
NP of hantaviruses for Ubc9 and SUMO-1. The consensus sequences in the NP of HTNV (Schumaljohn, C.S., et al., 1986) (41), Topografov virus (TOPV)
(Vapalahti, O., et al., 1999) (48), Puumala virus (PUUV) (Escutenaire, S., et al., 2001) (9), Prospect Hill (PHV) (Huang, C., et al., 1996) (15), and Sin Nombre
virus (SNV) (Spiropoulou, C.F., et al., 1994) (47) for the interactions with Ubc9 or SUMO-1 are shown in the table. The aa positions of the sequences
are shown at the right.
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Ubc9 and SUMO-1 (Table 1). In the case of substitutions
of K to A at aa 189 and E to A at aa 191, the interaction
between the mutated NPs and Ubc9 were significantly
lower than that between the wt-NP and Ubc9 (Table 1).
These results indicate that the region from aa 188–191 in
the NP of HTNV is responsible for the interaction with
Ubc9 and that K residue at aa189 of the NP is crucial for
the interaction.
We next examined the subcellular localization of mu-
tant NPs in mammalian cells. Red fluorescent protein
(RFP)-tagged wt-NP, NP-K189A, NP-E191A, NP-K189A/
E191A, NP-K189R, NP-E191D and NP188–191 were tran-
siently expressed in 293T cells (Fig. 5) or Vero E6 cells
(data not shown) by transfection with pDsRed2-HTN-NP,
pDsRed2-HTN-NP-K189A, pDsRed2-HTN-NP-E191A, pD-
sRed2-HTN-NP-K189A/E191A, pDsRed2-HTN-NP-K189R,
pDsRed2-HTN-NP-E191D, and pDsRed2-HTN-NP188–
191. We found that wt-NP, NP-K189A, NP-E191A, NP-
K189A/E191A, NP-K189R, and NP-E191D localized at the
perinuclear region, while NP188–191 dispersed into the
cytoplasm (Fig. 5, g-2). The mutant-NPs were similarly
stable in the transfected cells as estimated by Western
blot analysis (data not shown). These results indicate
that the difference in subcellular localization of NP188–
191 is not due to differences in the stability of the protein,
but rather due to the absence of the interaction with
SUMO-1.
DISCUSSION
During viral infection, many viral proteins are post-
translationally modified by viral or cellular enzymes,
through processes such as acetylation (43), methylation
(34), phosphorylation (3, 18, 33), glycosylation (11, 24, 36),
ubiquitination (5, 10, 13) and sumoylation (1, 14, 28).
These modifications may lead to protein-folding or un-
folding, viral assembly or disassembly, transportation of
the proteins in the infected cells, protein degradation,
and protein deaggregation.
Ubc9 covalently conjugates SUMO-1 to the substrates
at their internal K residues (sumoylation) (27). Sumoyla-
tion of the proteins alters the subcellular localization (27,
FIG. 4. Interaction between the NP of HTNV and SUMO-1 in yeast
cells. Y190 yeast cells were cotransformed with pAS2-1 (control bait
vector) and pACT2 (control prey vector) (a), pAS2-1 and pACT2-SUMO-1
(b), pAS2-1-HTN-NP and pACT2 (c), or pAS2-1-HTN-NP and pACT2-
SUMO-1 (d). Interactions were measured by -Gal assay. The bait
domain (DB), the NP, the prey domain (AD), and the SUMO-1 are
illustrated. The relative -Gal activities are shown as the -Gal activity
in the yeast cells cotransformed with each of the illustrated vectors
divided by that in the yeast cotransformed with pAS2–1 and pACT2 (a).
FIG. 5. Subcellular localization of the mutant NPs in living cells.
wt-NP (a-1 and a-2), NP-K189A (K189A) (b-1 and b-2), NP-E191A (c-1 and
c-2), NP-K189A/E191A (K189A/E191A) (d-1 and d-2) NP-K189R (K189R)
(e-1 and e-2), NP-E191D (E191D) (f-1 and f-2), and NP188–191 (188–
191) (g-1 and g-2) were expressed as RFP-conjugating forms in 293T
cells. pDsRed2-HTN-NP, pDsRed2-HTN-NP-K189A, pDsRed2-HTN-NP-
K189A/E191A, pDsRed2-HTN-NP-K189R, pDsRed2-HTN-NP-E191D, and
pDsRed2-HTN-NP188–191 were transfected into 293T cells. At
48 h.p.t., the expressed NPs were observed under a immunofluores-
cence microscopy at with (left panels) (a-1, b-1, c-1, d-1, e-1, f-1 and g-1)
or without (right panels) (a-2, b-2, c-2, d-2, e-2, f-2, and g-2) phase-
difference condensation, to see the subcellular localization of the NPs
and the red-fluorescence signals (RFP-signals), respectively.
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28) and the stability of the protein in cells (6), as well as
DNA replication and repair (25, 26).
The present results indicate that the aa 101–238 re-
gion in the NP of HTNV is necessary and sufficient for
Ubc9-binding. Li et al. (23) have recently reported the
interaction between the NP of Puumala virus (PUUV) and
SUMO-1; however, they did not define the region respon-
sible for the interaction nor discuss the significance of
the sumoylation of the NP in the PUUV-infected cells.
Other hantaviruses also have a consensus Ubc9 and
SUMO-1 binding motif in the NP (Fig. 3, B), so the inter-
action of the NP with Ubc9 and SUMO-1 may be a
common feature in hantaviruses.
To define the actual interaction region of the NP with
Ubc9 and SUMO-1, the binding consensus motif, MKAE,
at aa 188–191 in the NP of HTNV was deleted (NP188–
191). As expected, the interaction between the NP and
Ubc9 or SUMO-1 was completely abolished (Table 1).
Therefore, these 4 amino acids at aa 188–191 appear to
be crucial for the interaction between the NP and Ubc9
or SUMO-1. We then constructed several substitution
mutants of the NP. A substitution of K to R at aa 189 in the
HNTV-NP did not affect the interaction of NP with the
Ubc9 but reduced that with SUMO-1. A substitution of K
to A at aa 189, however, strongly affected the interaction
of the NP with both Ubc9 and SUMO-1. These results
suggest that the second amino acid in the motif is basic
for binding with Ubc9. Since sumoylation is occurs at the
K residue in general, SUMO-1 may indirectly bind the
mutant NPs such as NP-K189R and -K189A by binding
with the Ubc9 homolog of the yeast cells. Sampson et al.
(38) reported that the substitution of K to A residue within
the binding motif of the RanGAP1 abolished the interac-
tion with both Ubc9 and SUMO-1, while the substitution
of K to R abolished the interaction with SUMO-1 but not
with Ubc9 in an in vitro binding assay system. The
discrepancy between their observations and ours may
be due to differences in and the sensitivity of the assay
system employed or differences in the target proteins
analyzed. They also showed that the E residue in the
motif of the RanGAP1 is also important. In the present
study, the substitution of E to A and E to D at aa 191 of the
NP (NP-E191A and NP-E191D, respectively) did not affect
the interaction with either Ubc9 or SUMO-1, indicating
that the fourth amino acid in the motif is not crucial for
the interaction. However, we could not rule out the pos-
sibility that E residue at aa 192, the next amino acid
residue of the motif, compensated the function of E
residue at aa 191 in these mutant NPs.
In the present study, the interaction of the HTNV-NP
with Ubc9 or SUMO-1 was not associated with the pro-
teolysis of the NP since the steady-state levels of the
mutant NPs in mammalian cells estimated by Western
blot analysis were nearly the same as that of the wt-NP.
Rather, the differences in the localization patterns among
the mutant NPs in the cytoplasm were correlated with
the degree of interaction of the NP with Ubc9 or SUMO-1.
Thus, the interaction of the NP with Ubc9 or SUMO-1 is
likely to be necessary for the proper subcellular local-
ization of the NP. In the case of Black Creek Canal virus
(BCCV) (Fig. 1) (31), the C-terminal 141-aa residues of the
NP have been shown to target the green fluorescent
protein to the perinuclear region in the cells. The inter-
action of the NP with Ubc9 or SUMO-1 might alter the
conformation of the NP resulting in exposure of the
C-terminal perinuclear targeting sequence.
The C-terminal 93-aa residues of the NP of HTNV and
PUUV are reported to be important for the nonspecific
RNA binding of the NP (Fig. 1) (12). Severson et al. (44)
reported that the HTNV-NP preferentially binds to full-
length S-RNA. More recently, Xu et al. (50) showed that
the aa 197–218 region of the HTNV-NP contains the
major RNA binding determinants and that the aa 175–196
region contributes to the specificity of viral RNA recog-
nition (Fig. 1). Interestingly, this region overlaps with the
binding site of Ubc9 and SUMO-1. It would be of interest
to elucidate if the interaction of the NP with Ubc9 or
SUMO-1 affects the specificity of viral RNA recognition
by the NP.
Using a yeast two-hybrid screening system, Li et al.
(23) found that the PUUV-NP interacts with the Fas-
mediated apoptosis enhancer, Daxx, at the C-terminal
57-aa residues in the NP (Fig. 1). They hypothesized that
the interaction of the PUUV-NP with Daxx regulated the
localization of the NP and was involved in the apoptotic
process of the infected cells (23). Interestingly, Daxx in-
TABLE 1
The Interaction of the NPs with Ubc9 and SUMO-1
in the Yeast Cells
HTNV NPs Binding withb
NPs Sequencesa Ubc9 SUMO-1
Controlc  d e
wt-NP      AQSSMKAEEIT     
NP-K189A      AQSSMAAEEIT      
NP-E191A      AQSSMKAAEIT      
NP-K189A/E191A      AQSSMAAAEIT      
NP-K189R      AQSSMRAEEIT      
NP-E191D      AQSSMKADEIT      
NP-189–191      AQSS EIT      
a The amino acid sequence corresponding to 184–194 of the wt-NP of
HTNV was shown.
b -Gal activities of cotransformed yeast cells with pAS2-1 NPs and
pACT2 Ubc9 or pACT2 SUMO-1 were measured by -Gal assays as
described in the text.
c The empty vector, pAS2-1, was used as a negative control.
d The interactions were scored according to the rate of the negative
control (Control) as follows: 30, ; 20, ; 10, ; 1; ; 1;
.
e The interactions were scored according to the rate of the negative
control (Control) as follows:12,;8,;4,;1;;1;.
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teracts with Ubc9 and is covalently conjugated with
SUMO-1 in 293T cells (16, 37). Thus, it might be possible
that the complex of NP-Ubc9-SUMO-1-Daxx regulates
the subcellular localization of the HTNV-NP. Another re-
port indicated that the actin microfilament plays an im-
portant role in viral assembly in the BCCV-infected cells
(Fig. 1) (32). It is necessary to clarify how these cellular
factors are involved in the assembly of the NP and
whether these factors affect independently or coopera-
tively in the assembly process.
MATERIALS AND METHODS
Virus and cells
The 76–118 strain of HTNV (41) was used in the study.
Virus propagation and titration in Vero E6 cells were
carried out as described previously (41). Vero E6 and
293T cells were grown in Doulbeco’s modified minimum
essential medium (DMEM, GIBCO BRL) containing 5%
fetal calf serum (FCS) and 60 mg/ml of kanamycin.
Primers
The primers used for a polymerase chain reaction
(PCR) are listed in Table 2.
Yeast two-hybrid screening and interaction assay
The yeast two-hybrid bait plasmid, pAS2–1 (CLON-
TECH, Lab., Inc.), containing a cDNA of the open reading
frame (ORF) of the NP (referred to as pAS2–1-HTN-NP)
was constructed as follows. PCR was performed with
pGEM1-HTN-S (41) as a template and primers #1 and #2
using a High-fidelity PCR Kit (Roche). The PCR product
was cloned into the pGEMTeasy vector (Promega, re-
ferred to as pGEM-HTN-NP) and the sequence of the
insert was confirmed to be identical to the original se-
quence. pGEM-HTN-NP was digested with restriction
enzymes NcoI and BglII, and the digested DNA fragment
containing the ORF of the NP was inserted into the NcoI
and BamHI sites of pAS2–1 (pAS2–1-HTN-NP).
We used a cDNA library of HeLa cells cloned into
TABLE 2
Oligonucleotides Used in This Study
No. Primer name Sequence Binding site (protein) Polarity
Restriction
enzymes
#1 HTN NP1NcoI GGCCATGGCAACTATGGAGGAATTAC 1–22 (NP)  NcoI
#2 HTN-NP1290BglIIr GAGATCTTAGAGTTTCAAAGGCTCTTGG 1265–1290 (NP)  BglII
#3 UBC-r477 GCGGATCCTTATGAGGGCGCAAACTTCTTG 456–477 (Ubc9)  BamHI
#4 SUMO-1Br CGGATCCTAAACTGTTGAATGACCCCCCG 274–306 (SUMO-1)  BamHI
#5 UBC-f1 GGGATCCGAATGTCGGGGATCGCCCTCAGC 1–21 (Ubc9)  BamHI
#6 SUMO-1Bf GGGATCCACATGTCTGACCAGGAGGCAAAA 1–21 (SUMO-1)  BamHI
#7 N-100 GCCATGGATCCAGATGAGTTGAACAAG 103–123 (NP)  NcoI
#8 N-300 GGCCATGGTGCTGGATTTAAACCATTTGG 301–322 (NP)  NcoI
#9 N-400 GCCATGGCTCTGTATATGTTGACAACAAGG 409–432 (NP)  NcoI
#10 N-500 GGCCATGGATGTTAACGGTATCCGGAAAC 499–529 (NP)  NcoI
#11 N-600 GGCCATGGCAGTCTGTGGGCTCTACCCTGC 601–623 (NP)  NcoI
#12 C-100 GGAGATCTATCCCCTAAGTGGAAGTTGTC 1180–1200 (NP)  BglII
#13 C-400 GGAGATCTAATATCTTCAATCATGCTACAG 876–897 (NP)  BglII
#14 C-600 GGAGATCTACTCCAGTCCTTTGCTAATGC 679–699 (NP)  BglII
#15 HTN NP425f AACAAGGGGGAGGCAAACTACC 426–447 (NP) 
#16 d88-91r CTATATCTACCAGGTGTAATCTCaGCTTGACTGTGCATTTGGCAAG 540–561,574–596 (NP) 
#17 d88-91f CTTGCCAAATGCACAGTCAAGCbGAGATTACACCTGGTAGATATAG 540–561,574–596 (NP) 
#18 HTN NP747r GTATCTGGAAGAAGCTTGCAAG 728–749 (NP) 
#19 K189Rr GTAATCTCTTCTGCCC TCATGCTTGACTG 543–571 (NP) 
#20 K189Rf CAGTCAAGCATGAGGGCAGAAGAGATTAC 543–571 (NP) 
#21 K189Ar GTAATCTCTTCTGCCGCCATGCTTGACTG 543–571 (NP) 
#22 K189Af CAGTCAAGCATGGCGGCAGAAGAGATTAC 543–571 (NP) 
#23 E191Dr GTAATCTCG TCTGCCTTCATGCTTGACTG 543–571 (NP) 
#24 E191Df CAGTCAAGCATGAAGGCAGAC GAGATTAC 543–571 (NP) 
#25 E191Ar GTAATCTCTGCTGCCTTCATGCTTGACTG 543–571 (NP) 
#26 E191Af CAGTCAAGCATGAAGGCAGC AGAGATTAC 543–571 (NP) 
#27 K189A/E191Ar GTAATCTCTG CTGCTGCCATGCTTGACTG 543–571 (NP) 
#28 K189A/E191Af CAGTCAAGCATGGCAGC AGCAGAGATTAC 543–571 (NP) 
#29 HTN-NP1-XbaI CCTCTAGAATGGCAACTATGGAGGAATTAC 1–22 (NP)  XbaI
#30 HTN-NP1290-KpnI CCGGTACCTTAGAGTTTCAAAGGCTCTTG 1266–1290 (NP)  KpnI
#31 UBC9f1-BamHI CCGGATCCATGTCGGGGATCGCCCTCAGC 1–21 (Ubc9)  BamHI
a: The sequence, TTCTGCCTTCAT, was deleted from the anti-sense sequence of the NP at 540 to 596-nt.
b: The sequence, ATGAAGGCAGAA, was deleted from the sense sequence of the NP at 540 to 596-nt.
: Mutations were introduced in the boxed sequences.
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pACT2, pACT2-HeLa-cDNA library (CLONTECH, Lab.,
Inc.), consisting of 1  106 independent clones of the
screening targets against the NP. We used the yeast
two-hybrid Kit (CLONTECH, Lab., Inc.) to screen the li-
brary according to the manufacturer’s instructions.
Briefly, we cotransformed yeast Y190 cells with pAS2–1-
HTN-NP and pACT2-HeLa-cDNA library and then se-
lected the transformants on the yeast growing plates
depleted by three nutritions: tryptophan and leucine as
the selectable markers of the transformants of pAS2–1
and pACT2 vectors, respectively, and histidine as the
interaction marker. To estimate the protein-protein inter-
actions in the yeast cells, we employed a filter lift assay,
a standard protocol to detect lacZ-expression using
5-bromo-4-chloro-3-indolyl--D-galactopyranoside (X-Gal),
or a -Gal assay (Galacto-Light, TROPIX, M.A., U.S.A.) to
quantify the -Gal activity. For the -Gal assay, the yeast
cells (2  106 cells) were frozen and thawed, and mixed
with a reaction buffer containing Galacton as a substrate.
The reaction mixture was incubated at room temperature
for one hour and then the acceleration solution was added
to the mixture. Light Units (LU) per 5 sec (s) were counted
by a luminometer (Microtech NITI-ON, Inc., Japan). All the
media and reagents for yeast culture were purchased from
CLONTECH, Lab., Inc.
Analysis of the interaction between HTNV-NP and
Ubc9 or SUMO-1 in yeast cells.
The cDNAs of Ubc9 and SUMO-1 were synthesized
from mRNAs extracted from HeLa cells by reverse tran-
scription reaction using primers #3 and #4, respectively.
The cDNAs were amplified by PCR using primers #5 and
#3, #6 and #4, respectively. The PCR products were
digested with a restriction enzyme, BamHI, and cloned
into the BamHI site of a prey vector, pACT2, for a sense
direction (referred to as pACT2-Ubc9 and pACT2-
SUMO-1, respectively).
A series of deletion mutations were introduced into the
NP gene by the PCR-based procedure. PCRs were per-
formed using pGEM-HTN-NP as a template and each of
the following sets of primers; #7 and #2 for pAS2-1-HTN-
NP1–30, #8 and #2 for pAS2-1-HTN-NP1–100, #9 and
#2 for pAS2-1-HTN-NP1–133, #10 and #2 for pAS2-1-
HTN-NP1–166, #11 and #2 for pAS2-1-HTN-NP1–199,
#1 and #12 for pAS2-1-HTN-NP401–429, #1 and #13 for
pAS2-1-HTN-NP334–429, and #1 and #14 for pAS2-1-
HTN-NP239–429. Each PCR product was digested with
restriction enzymes, NcoI and BglII, and cloned into the
NcoI and BamHI sites of pAS2–1. To construct the HTN-
NP169–429 expression vector, pAS2-1-HTN-NP169–
429, the PCR fragment amplified with primers #1 and #2
was digested with restriction enzymes, NcoI and HpaI,
and then the small DNA fragment was cloned into the
NcoI and SmaI site of pAS2-1.
To introduce a 4-aa deletion, MKAE, at the aa position
between 188 and 191, recombinant PCRs were per-
formed. First PCRs were performed using primers #15
and #16, #17 and #18 and pGEM-HTN-NP as a template.
Subsequent PCRs were carried out using primers #15
and #18 as primers, and #15/#16 and #17/#18 products
as templates. The PCR product was digested with re-
striction enzymes, HpaI and HindIII, and then used to
replace the same region of the pGEM-HTN-NP at the
HpaI and HindIII sites (referred to as pGEM-HTN-
NP188–191). The mutated HTNV-NP fragment was sep-
arated from pGEM-HTN-NP188–191 by digestion with
restriction enzymes, NcoI and BglII, and cloned into the
NcoI and BamHI sites of pAS2–1 to construct pAS2–1-
HTN-NP188–191. pGEM-HTN-NP and pAS2-1-HTN-NP
containing a substitution mutation, K to R at aa 189
(referred to as pGEM-HTN-NP-K189R and pAS2-1-HTN-
NP-K189R), K to A at aa 189 (referred to as pGEM-HTN-
NP-K189A and pAS2-1-HTN-NP-K189A), E to D at aa 191
(referred to as pGEM-HTN-NP-E191D and pAS2-1-HTN-
NP-E191D), E to A at aa 191 (referred to as pGEM-HTN-
NP-E191A and pAS2-1-HTN-NP-E191A), and K to A at aa
189/E to A at aa 191 (referred to as pGEM-HTN-NP-
K189A/E191A and pAS2-1-HTN-NP-K189A/E191A) were
similarly constructed using primers #15, #19, #20 and
#18; #15, #21, #22 and #18; # 15, #23, #24 and #18; # 15,
#25, #26 and #18; and; # 15, #27, #28 and #18, respec-
tively, in recombinant PCRs.
Mammalian two-hybrid interaction assay
To demonstrate the interaction between the HTNV-NP
and Ubc9 in mammalian cells, mammalian two-hybrid
plasmids were constructed. To construct a bait vector,
pBIND-HTN-NP, the PCR product of the NP amplified
using primers #29 and #30, was digested with restriction
enzymes, XbaI and KpnI, and inserted into the XbaI and
KpnI site of a bait plasmid, pBIND (Promega). To con-
struct a prey vector, pACT-Ubc9, the PCR product of Ubc9
amplified using primers #3 and #5 was digested with
BamHI and then inserted into the BamHI site of a prey
plasmid, pACT (Promega), for a sense direction (referred
to as pACT-Ubc9).
To examine the protein-protein interactions in mam-
malian cells, 293T or Vero E6 cells were transiently
transfected with 3 mammalian two-hybrid vectors, a
pBIND construct, a pACT construct and pG5luc vectors
(CheckMate Mammalian Two-Hybrid System, Promega)
using FuGENE6 transfection reagent (Roche). When two
proteins expressed from the pBIND and pACT constructs
interact with each other, the Firefry luciferase encoded in
pG5luc should be expressed through the activation of its
promoter. Additionally, we examined transfection effi-
ciency by monitoring the expression of Renilla luciferase
as an internal marker, which is encoded in the pBIND
vector and is expressed under the control of a human
cytomegalovirus immediate-early (CMV-IE) promoter in
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the transfected cells. We normalized the protein-protein
interactions in mammalian cells by the formula: Interac-
tion units (ratio)	 LU obtained from Firefry luciferase/LU
obtained from Renilla luciferase Luciferase activities
were measured by the luciferase assay system (Dual-
Luciferase Reporter Assay System, Promega) according
to the manufacturer’s instructions. Briefly, the cells were
harvested and lysed at 48 h post transfection (h.p.t.), and
the lysates were mixed with LARII reagent. The activities
of Firefry luciferase were measured for 30 s. STOP & Glo
reagent was then added to the reactions and the activity
of Renilla luciferase was immediately measured for 30 s.
Analysis of subcellular localization of the NP and
Ubc9 in mammalian cells
A vector, pEGFP-C1-Ubc9, to express a fusion protein
of EGFP and Ubc9, was constructed as follows. The
cDNA of Ubc9 was amplified using primers #31 and #3
and the PCR product was digested with BamHI and then
inserted into the BamHI site of a pEGFP-C1 plasmid-
(CLONTECH, Lab., Inc.). To construct vectors expressing
the wt- and mutant-NPs tagged with RFP, pGEM-HTN-NP,
pGEM-HTN-NP188–191, pGEM-HTN-NP-K189A, pGEM-
HTN-NP-K189R, pGEM-HTN-NP-E191A, pGEM-HTN-NP-
E191D, and pGEM-HTN-NP-K189A/E191A were digested
with NcoI and filled-in using a Klenow fragment of DNA
polymerase I, and then digested with BglII. The frag-
ments containing wt- and mutant-NPs were purified and
inserted into the SmaI and BamHI site of the pD-
sRed2-C1 vector (CLONTECH, Lab., Inc.), referred to as
pDsRed2-HTN-NP for a wt-NP, pDsRed2-HTN-NP188–
191, pDsRed2-HTN-NP-K189A, pDsRed2-HTN-NP-
K189R, DsRed2-HTN-NP-E191A, pDsRed2-HTN-NP-E191D,
and pDsRed2-HTN-NP-K189A/E191A for mutant NPs, re-
spectively.
The cells transfected with the expression vectors or
the HTNV-infected cells were fixed in a mixture of 50%
methanol and 50% acetone. The fixed cells were reacted
with a monoclonal antibody (MAb) against the NP of
HTNV, C16D11 (51), at a dilution of 1:200. The cells
were then reacted with a rhodamine-conjugated anti-
mouse IgG antibody (Zymed) and examined for staining
pattern under a immunofluorescence microscope (Zeiss,
HBO50/AC, Germany).
293T or Vero E6 cells were transfected with the vec-
tors for expressing the RFP-tagged NPs using FuGENE6
transfection reagent. After 48 h.p.t., the subcellular local-
ization of the expressed proteins was monitored without
fixation under a immunofluorescence microscope (Olym-
pus, CK40, Japan) .
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